SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-16-789419
Filing Date
2016-12-09
Accepted
2016-12-09 11:57:32
Documents
2
Group Members
ANDREW D. WINGATE

Document Format Files

Seq Description Document Type Size
1 SC 13G d309324dsc13g.htm SC 13G 51507
2 EX-99.1 d309324dex991.htm EX-99.1 3886
  Complete submission text file 0001193125-16-789419.txt   57166
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 162043230
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O GEORGE BRENCHER 271 WHITNEY AVENUE NEW HAVEN CT 06511
Business Address C/O GEORGE BRENCHER 271 WHITNEY AVENUE NEW HAVEN CT 06511 203-772-2600
KLP Enterprises, LLC (Filed by) CIK: 0001593399 (see all company filings)

IRS No.: 201336102 | State of Incorp.: DE | Fiscal Year End: 1213
Type: SC 13G